Cargando…

Dermoscopic assessment of skin toxicities in patients with melanoma during treatment with vemurafenib

INTRODUCTION: The use of vemurafenib in melanoma has improved the survival of patients; however, it is associated with skin toxicities. AIM: To assess skin toxicities by dermoscopy in patients treated with vemurafenib. MATERIAL AND METHODS: Eight patients with BRAF V600 mutation positive metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajczykowski, Marcin, Kaminska-Winciorek, Grazyna, Nowara, Elzbieta, Samborska-Plewicka, Marzenna, Giebel, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872245/ https://www.ncbi.nlm.nih.gov/pubmed/29599670 http://dx.doi.org/10.5114/ada.2018.73163

Ejemplares similares

Metaplastic breast carcinomas – analysis of prognostic factors in a case series
por: Nowara, Elżbieta, et al.
Publicado: (2014)

Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2016)

Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib
por: Nowara, Elzbieta, et al.
Publicado: (2016)

Dermoscopic Evolution of Mycosis Fungoides After Allogeneic Hematopoietic Stem Cell Transplantation: a Case Series
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2023)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

“Mistletoe sign”: probably a new dermoscopic descriptor for melanoma in situ and melanocytic junctional nevus in the inflammatory stage
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Rare presentation of eczema-like amelanotic melanoma of the forearm with its dermoscopic differentiation
por: Słowińska, Monika A., et al.
Publicado: (2019)

Melanoma awareness and prevalence of dermoscopic examination among internet users: a cross-sectional survey
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2016)

Clinical manifestations of diffuse large B-cell lymphoma in the skin and subcutaneous tissue a case series study
por: Dulik, Katarzyna, et al.
Publicado: (2020)

Agminated blue nevi: a case series and updated dermoscopic review
por: Sławińska, Martyna, et al.
Publicado: (2022)

Basal Cell Carcinoma Treated with High Dose Rate (HDR) Brachytherapy—Early Evaluation of Clinical and Dermoscopic Patterns during Irradiation
por: Krzysztofiak, Tomasz, et al.
Publicado: (2021)

Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer’s Response
por: Krzysztofiak, Tomasz, et al.
Publicado: (2023)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

Lesion- and Patient-Related Variables May Provide Additional Clues during Dermoscopic Assessment of Blue Nevi—A Retrospective Cohort Study
por: Sławińska, Martyna, et al.
Publicado: (2022)

The dermoscopic variability of Degos disease at different stages of progression
por: Anker, Javiera Pérez, et al.
Publicado: (2014)

Melanoma as a surprising solution to the puzzle of intestinal obstruction
por: Gajda, Maksymilian, et al.
Publicado: (2016)

An unusual case of compound naevus of the scalp with hair greying, suggesting melanoma in dermoscopy
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2020)

Dermoscopy of nodular skin metastases from the gastrointestinal primary cancer
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2015)

“Better do not touch” and other superstitions concerning melanoma: the cross-sectional web-based survey
por: Gajda, Maksymilian, et al.
Publicado: (2016)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
por: Zhou, Hong, et al.
Publicado: (2023)

Metastatic melanoma and vemurafenib: novel approaches
por: De Mello, Ramon Andrade
Publicado: (2012)

A STATement on Vemurafenib-Resistant Melanoma
por: Hartsough, Edward J., et al.
Publicado: (2013)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

RASopathic Skin Eruptions during Vemurafenib Therapy
por: Rinderknecht, Jeannine D., et al.
Publicado: (2013)

Dermoscopy of Small Diameter Melanomas with the Diagnostic Feasibility of Selected Algorithms—A Clinical Retrospective Multicenter Study
por: Slowinska, Monika, et al.
Publicado: (2021)

Dermoscopy of halo nevus in own observation
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2014)

Dermoscopy on nevus comedonicus: a case report and review of the literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Tips and tricks in the dermoscopy of pigmented lesions
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2012)

The most common mistakes on dermatoscopy of melanocytic lesions
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2015)

Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
por: Olbryt, Magdalena, et al.
Publicado: (2020)

Correction: RASopathic Skin Eruptions during Vemurafenib Therapy
por: Rinderknecht, Jeannine D., et al.
Publicado: (2013)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
por: Cui, Hongmei, et al.
Publicado: (2021)

Vemurafenib induces a noncanonical senescence-associated secretory phenotype in melanoma cells which promotes vemurafenib resistance
por: Peng, Jianyu, et al.
Publicado: (2023)

Managing Side Effects of Vemurafenib Therapy for Advanced Melanoma
por: Hagen, Brenda, et al.
Publicado: (2014)

Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
por: Osrodek, Marta, et al.
Publicado: (2020)

Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis
por: Tang, Fengjie, et al.
Publicado: (2020)

What Do the Lips Say in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation? A Case Series
por: Szlauer-Stefańska, Anastazja, et al.
Publicado: (2021)

Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma
por: Tahseen, Ahmed I., et al.
Publicado: (2018)

Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
por: Ziętek, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufc642up7h1svs143q3reg0qe6